Suppr超能文献

腹腔镜子宫肌瘤剔除术中应用血管加压素:是否真的扩大了其适应证范围?

Vasopressin during Laparoscopic Myomectomy: Does It Really Extend Its Limits?

机构信息

Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, "Alexandra" Hospital, Athens, Greece.

Department of Obstetrics and Gynecology, Medical School, National and Kapodistrian University of Athens, "Alexandra" Hospital, Athens, Greece.

出版信息

J Minim Invasive Gynecol. 2019 Mar-Apr;26(3):441-449. doi: 10.1016/j.jmig.2018.05.011. Epub 2018 May 18.

Abstract

STUDY OBJECTIVE

Τo investigate whether the use of vasopressin played an important role in the safe expansion of the indications of laparoscopic myomectomy in our practice.

DESIGN

A retrospective comparison of prospectively collected data (Canadian Task Force classification II2).

SETTING

A gynecologic endoscopy unit in a tertiary university hospital.

PATIENTS

One hundred fifty patients undergoing laparoscopic myomectomy; 50 were treated without the use of any vasoconstrictive agent (group 1), and 100 were treated with intraoperative intramyometrial injection of dilute vasopressin (20 IU/100 mL normal saline) (group 2).

INTERVENTIONS

Laparoscopic myomectomy.

MEASUREMENTS AND MAIN RESULTS

We compared the 2 groups in terms of size, number, and type of myomas; estimated blood loss (EBL); procedure length; transfusion rates; laparoconversion rates; and rates of complications. Two cases in group 1 (4%) were laparoconverted versus none (0%) in group 2. Overall, the mean EBL was 321.8 ± 246.0 mL in group 1 compared with 147.8 ± 171.8 mL in group 2, respectively (p <.001). Additionally, EBL was significantly lower in the vasopressin group in all of the study's subgroups of patients stratified according to the size and number of myomas. Procedure length did not differ significantly between the 2 groups (130.8 ± 49.5 vs 115.6 ± 49.4 minutes, p = .078). The risk factors for prolongation of the procedure included size and number of myomas independently of vasopressin. The rates of hypercapnea and subcutaneous emphysema were higher in group 1. The risk factors for hypercapnea and subcutaneous emphysema included the size and intramural position of the largest myoma. Vasopressin was not associated with serious cardiovascular adverse events.

CONCLUSIONS

Vasopressin is effective in reducing blood loss during laparoscopic myomectomy. Although experienced surgeons may achieve comparable operation times without vasopressin, even in the most challenging cases, blood loss may still be considerable. The occurrence of hypercapnea is higher in untreated cases and may contribute to laparoconversion.

摘要

研究目的

研究血管加压素的应用是否在我们的实践中腹腔镜子宫肌瘤切除术适应证的安全扩展中发挥了重要作用。

设计

前瞻性收集数据的回顾性比较(加拿大任务组分类 II2)。

设置

一家三级大学医院的妇科内镜单位。

患者

150 名接受腹腔镜子宫肌瘤切除术的患者;50 名未使用任何血管收缩剂治疗(第 1 组),100 名接受术中肌内注射稀释血管加压素(20 IU/100 mL 生理盐水)(第 2 组)。

干预措施

腹腔镜子宫肌瘤切除术。

测量和主要结果

我们比较了 2 组在肌瘤的大小、数量和类型、估计失血量(EBL)、手术时间、输血率、腹腔镜转换率和并发症发生率方面的差异。第 1 组中有 2 例(4%)转为腹腔镜手术,而第 2 组中无(0%)转为腹腔镜手术。总体而言,第 1 组的平均 EBL 为 321.8 ± 246.0 mL,而第 2 组为 147.8 ± 171.8 mL(p <.001)。此外,在根据肌瘤大小和数量分层的所有患者亚组中,血管加压素组的 EBL 明显低于对照组。2 组手术时间无显著差异(130.8 ± 49.5 与 115.6 ± 49.4 分钟,p =.078)。手术时间延长的危险因素包括肌瘤的大小和数量,与血管加压素无关。第 1 组的高碳酸血症和皮下气肿发生率较高。高碳酸血症和皮下气肿的危险因素包括最大肌瘤的大小和肌内位置。血管加压素与严重心血管不良事件无关。

结论

血管加压素可有效减少腹腔镜子宫肌瘤切除术中的出血量。尽管经验丰富的外科医生在不使用血管加压素的情况下可能实现相似的手术时间,但即使在最具挑战性的情况下,出血量仍可能相当大。未治疗病例中高碳酸血症的发生率较高,可能导致腹腔镜转换。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验